Liver transplant-facilitated CD161+Vα7.2+ MAIT cell recovery demonstrates clinical benefits in hepatic failure patients

Liver transplant-facilitated CD161+Vα7.2+ MAIT cell recovery demonstrates clinical benefits in hepatic failure patients Consider to be published in nature communications, 2025 Wei Wang1#, Chen Dai2#, Peng Zhu3, Mi Wu1, Haoquan Zhang3, Qing Wei4, Ting Zhou1, Xiaosheng Tan2, Ying Jiang1, Xue Cheng1, Zhihui Liang1, Xiongwen Wu1, Zhishui Chen2*, Xiufang Weng1,2,4* 1 Department of Immunology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Disease, Huazhong University of Science and Technology, Wuhan China, 430030 2 Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Transplantation; Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan China, 430030 3 Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 430030 4 Department of Transfusion, Tongji Hospital, Tongji Medical College, Huazhong University of Science and technology, Wuhan, China, 430030 # These authors contributed equally to this manuscript. * Corresponding authors. E-mail: [email protected] (Xiufang Weng); [email protected] (Zhishui Chen) https://github.com/wendyweb200911/2024NC